Ignite Creation Date:
2025-12-26 @ 11:00 AM
Ignite Modification Date:
2026-02-28 @ 7:29 AM
Study NCT ID:
NCT01328106
Status:
WITHDRAWN
Last Update Posted:
2017-12-12
First Post:
2010-03-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety Study of GSK1120212, a MEK Inhibitor, in Subjects With Uveal Melanoma
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-11
Start Date Type:
None
Primary Completion Date:
2011-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2012-05
Completion Date Type:
ESTIMATED
First Submit Date:
2010-03-18
First Submit QC Date:
None
Study First Post Date:
2011-04-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-08
Last Update Post Date:
2017-12-12
Last Update Post Date Type:
ACTUAL